Exploring Dietary Supplement Utilization Patterns Among African American Survivors of Prostate and Breast Cancer: A Cross-Sectional Analysis
Open Access
- 27 November 2025
- Vol. 17 (23) , 3724
Abstract
Background/Objectives: Cancer survivors are a growing population in the United States, with projections of 22.5 million by 2030. Cancers of the prostate (PC) and breast (BC) are among the most prevalent. Despite a high burden of disease, African American survivors are underrepresented in health behavior research. Leveraging two large databases, this study uniquely characterizes dietary supplement (DS) use among African American cancer survivors to explore potential intervention points. Methods: Characteristics from 376 African American cancer survivors (130 PC; 246 BC) in lifestyle intervention trials were examined. DS use was self-reported and categorized by type. A logistic regression model examined associations between use and survivor characteristics. Results: Overall, 215 (63.80%) survivors with baseline medication log data (N = 337) reported using at least one DS, with a higher prevalence among BC survivors (67.44%) than PC survivors (57.38%). Vitamin D ± calcium combinations, multivitamins, omega-3 fatty acids, calcium, Vitamin B12, and Vitamin C were the most frequently reported. Total comorbidities (mean = 2.38, SD = 1.66) significantly predicted increased DS use among BC and PC survivors. Educational attainment (≤12th grade vs. graduate/professional education) and diet quality (high vs. low) were significantly associated with lower odds of DS use for PC survivors. Only diet quality (moderate vs. low) was significantly associated with higher odds of DS use in BC survivors. Conclusions: DS use is common among African American PC and BC survivors participating in lifestyle interventions. These findings underscore the need for evidence-based guidelines regarding DS use among cancer survivors and the need to include diverse populations.Keywords
Funding Information
- National Cancer Institute (R01CA154406, R01CA229546)
This publication has 31 references indexed in Scilit:
- Trends in dietary supplement use among U.S. adults between 2011 and 2023European Journal of Nutrition, 2025
- Label Statements and Perceived Health Benefits of Dietary SupplementsJAMA Network Open, 2025
- The Limited Value of Multivitamin SupplementsJAMA Network Open, 2024
- Physical activity and dietary considerations for prostate cancer patients: future research directionsProceedings of the Nutrition Society, 2023
- Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and CancerJAMA, 2022
- Dietary supplement use by individuals living with and beyond breast, prostate, and colorectal cancer: A cross‐sectional surveyCancer, 2021
- Dietary Supplement Use after Cancer Diagnosis in Relation to Total Mortality, Cancer Mortality and Recurrence: A Systematic Review and Meta-AnalysisNutrition and Cancer, 2020
- Diagnoses associated with dietary supplement use in a national datasetComplementary Therapies in Medicine, 2019
- Update of the Healthy Eating Index: HEI-2015Journal of the Academy of Nutrition and Dietetics, 2018
- Dietary supplement use among elderly, long-term cancer survivorsJournal of Cancer Survivorship, 2008